
What happened
Fuller H B Co (NYSE: FUL) director Daniel L. Florness bought 2,030 shares on 2026-09-28 at $49.34 each, the filing says. The purchase totaled about $100,160. His beneficial ownership rose to 3,381 shares after the trade.
The form says the shares were held directly. It also says 2,030 of them were in a joint account with his spouse.
Those units will be converted into shares of common stock upon retirement, death, disability or certain specified events, as defined in the plan, subject to holding periods required by law.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Shares bought | 2,030 shares | SEC Form 4 | |
| Price per share | $49.34 | SEC Form 4 | |
| Purchase value | about $100,160 | SEC Form 4 | |
| Shares held after | 3,381 shares | SEC Form 4 | |
| Purchase size vs prior holding | about 150.3% | Calculated from SEC Form 4 |
Read more: Fuller H B (FUL) stock analysis and investment case
Why it matters
OptimistFi's case is that H.B. Fuller can create value if its specialty adhesives remain specified, application-critical inputs that support pricing and margin expansion despite low-growth end markets. A director's purchase strengthens that view. The 2,030 shares were about 150.3% of the holding before the trade.
That ratio comes from OptimistFi's calculation using the filing's reported buy and the pre-trade holding. The trade is not proof of earnings momentum, but it does show a director putting fresh capital to work at the reported price.
The filing is still just one ownership snapshot, so it is better read as a sentiment signal than as operating evidence. Even so, a buy this large relative to the prior stake is a clear sign in the form.
The form also says 2,030 shares were held in a joint account with his spouse, and 33,616.06 stock units remained afterward.
Related: H.B. Fuller Company (NYSE: FUL) Raised Prices as Volume Fell
What's next
The next quarterly report is the next scheduled test for whether the business still supports pricing and margin expansion. If Fuller H B Co shows those trends intact, the purchase will fit better with OptimistFi's case.
If the report shows pressure instead, this insider buy will matter less as a sign about fundamentals. Until then, the filing mainly shows that a director added shares and ended with 3,381 shares beneficially owned.
That leaves the operating case unchanged, while modestly strengthening the ownership signal.
More from OptimistFi
- FUL stock: the Fuller H B thesis, its status and the next test to watch
- Eli Lilly and Company (NYSE: LLY) EloraTZP Adds Weight Loss and More Dropouts
- Momentus Inc. (NASDAQ: MNTS) Completes NASA Satellite Test
- Tesla, Inc. (NASDAQ: TSLA) Q3 Consensus Splits Cars and Energy
- Stock research on every company OptimistFi covers
- Latest stock research and investment-case updates
- OptimistFi: evidence-first equity research
Sources
- SEC Form 4 — Insider purchase filing for Daniel L. Florness
Read the full OptimistFi thesis on Fuller H B Co: https://optimistfi.com/stocks/FUL
See what would break the Fuller H B Co thesis and track it live on the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
The full Fuller H B Co investment case, its status and the next test to watch live on the Fuller H B Co thesis page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
